- You are viewing a Navigating Care library resource.
- Back to Library
Chronic Myelomonocytic Leukemia
Chronic myelomonocytic leukemia is a disease in which too many myelocytes and monocytes (immature white blood cells) are made in the bone marrow.
In chronic myelomonocytic leukemia (CMML), the body tells too many blood stem cells to become two types of white blood cells called myelocytes and monocytes. Some of these blood stem cells never become mature white blood cells. These immature white blood cells are called blasts. Over time, the myelocytes, monocytes, and blasts crowd out the red blood cells and platelets in the bone marrow. When this happens, infection, anemia, or easy bleeding may occur.
Older age and being male increase the risk of chronic myelomonocytic leukemia.
Anything that increases your chance of getting a disease is called a risk factor. Possible risk factors for CMML include the following:
- Older age.
- Being male.
- Being exposed to certain substances at work or in the environment.
- Being exposed to radiation.
- Past treatment with certain anticancer drugs.
Signs and symptoms of chronic myelomonocytic leukemia include fever, weight loss, and feeling very tired.
These and other signs and symptoms may be caused by CMML or by other conditions. Check with your doctor if you have any of the following:
- Fever for no known reason.
- Infection.
- Feeling very tired.
- Weight loss for no known reason.
- Easy bruising or bleeding.
- Pain or a feeling of fullness below the ribs.
Certain factors affect prognosis (chance of recovery) and treatment options.
The prognosis and treatment options for CMML depend on the following:
- The number of white blood cells or platelets in the blood or bone marrow.
- Whether the patient is anemic.
- The amount of blasts in the blood or bone marrow.
- The amount of hemoglobin in red blood cells.
- Whether there are certain changes in the chromosomes.
Learn more:
- General Information About Myelodysplastic/ Myeloproliferative Neoplasms
- Chronic Myelomonocytic Leukemia
- Juvenile Myelomonocytic Leukemia
- Atypical Chronic Myelogenous Leukemia
- Myelodysplastic/ Myeloproliferative Neoplasm, Unclassifiable
- Stages of Myelodysplastic/ Myeloproliferative Neoplasms
- Treatment Option Overview
- Treatment of Chronic Myelomonocytic Leukemia
- Treatment of Juvenile Myelomonocytic Leukemia
- Treatment of Aypical Chronic Myelogenous Leukemia
- Treatment of Myelodysplastic/ Myeloproliferative Neoplasm, Unclassifiable
- To Learn More About Myelodysplastic/ Myeloproliferative Neoplasms
Related Articles
- General Information About Myelodysplastic/ Myeloproliferative Neoplasms
- Chronic Myelomonocytic Leukemia
- Juvenile Myelomonocytic Leukemia
- Atypical Chronic Myelogenous Leukemia
- Myelodysplastic/ Myeloproliferative Neoplasm, Unclassifiable
- Stages of Myelodysplastic/ Myeloproliferative Neoplasms
- Treatment Option Overview
- Treatment of Chronic Myelomonocytic Leukemia
- Treatment of Juvenile Myelomonocytic Leukemia
- Treatment of Aypical Chronic Myelogenous Leukemia
- Treatment of Myelodysplastic/ Myeloproliferative Neoplasm, Unclassifiable
- To Learn More About Myelodysplastic/ Myeloproliferative Neoplasms